Texas Prior Authorization Regulation: The Gold Card Pioneers

Texas set a standard for gold card reform, holding a huge share in the market influence of state-specific regulation. Texas remains the reference point for lawmakers when considering their own gold card reform, and the Texas bills serve as a template for other states to build upon and edit for their own specific needs.

‍

The Original Gold Card Mandate (HB 3459)

‍

Texas House Bill 3459 took effect September 1, 2021, and applies to requests made from January 1, 2022 onward. The setup is well-structured and simple on paper: a provider who earns a 90% approval rate on a given service over a six-month period qualifies for a continuous exemption, or “gold card,” from prior authorization requests on that service. What seems simple is actually a huge advancement for providers – especially specialists and providers rendering the same services with the same authorization criteria repeatedly. The simplicity of the law was, in part, what made it so easy to follow for other states. Arkansas, Colorado, Louisiana, West Virginia, and Wyoming have all since passed their own variation of the bill, each adapting the basic structure to their own specific set of pain points and scopes.

‍

That being said, it’s notable the breadth of this original Texas law is actually quite narrow, even though it is harrowed quite differently in media coverage. According to the Texas Medical Association, HB 3459 applies only to TDI-regulated HMO, PPO, and EPO commercial plans, a segment covering roughly 20% of Texans – a significant burden lift, but only 1/5th of insured Texans stand to benefit from the original bill. Medicaid and CHIP are entirely excluded. These scope nuances matter intensely to a Texas provider trying to grasp the volume will be exempted from qualifying for gold card status. 

‍

Extending the Evaluation Window (HB 3812)

‍

Passed in 2025 and effective September 1, 2026, HB 3812 is a testament to the commitment of Texas lawmakers to actually addressing the problems their providers are facing. Once the original law had been in effect, provider feedback expressed six months was too short of a window for many clinicians and practices to accumulate enough requests on a given service to pass the required threshold.

‍

In response, HB 3812 extends the evaluation period to a full year. Similarly to their first bill, this bill allows other states to learn from this experiment and likely pass their first bills with a long evaluation period. Further, this change reflects a useful lesson:  gold carding. A high-volume specialty group might clear a six-month bar with ease, while a smaller independent practice needs the additional cushion to generate enough requests to qualify at all.

‍

Texas Joins the AI-Oversight Wave (SB 815)

‍

A separate law, SB 815, prohibits insurers from letting AI issue any adverse prior authorization determinations without the direct oversight or final call from a human being. This places Texas alongside California, Georgia, Maryland, and Nebraska in the growing group of states requiring that a licensed clinician make or review adverse outcomes, rather than allowing an algorithm to issue one.

‍

The practical effect is that Texas now sits in two of the four major categories of state prior authorization reform simultaneously: gold carding and AI oversight. This cements Texas as one of the more comprehensive states, tackling multiple prior authorization burdens across multiple bills. Other states, like North Dakota, placed all comprehensive reform in one major bill – Texas’ approach is a piecemeal one, but allows for incremental changes over time rather than waiting to pass it in one fell swoop.

‍

What This Means Operationally

‍

For a health system, clinical practice, or infusion clinic practicing and operating in Texas, there are three key things to note about the operational effects of these bills.

‍

First, the plan-type limitation on HB 3459 means gold card eligibility is evaluated at a line-level, not organization-wide. A provider’s eligibility is evaluated from patients with a specific plan type – only about 20% – and not against all approvals across the given service. What matters is the approval rate on a specific service, with a specific TDI-regulated plan, over the applicable evaluation period, which is a relatively specific scope.

‍

Second, the shift from a six-month to a twelve-month evaluation period under HB 3812 changes the timeline for when a newly qualifying provider or service can expect to see exemption status take effect. Organizations that were tracking toward gold card eligibility under the original six-month standard need to extend their plans for the new 12-month period, delaying eligibility for high-volume providers.

‍

Third, SB 815's AI-oversight requirement changes what a denial in Texas actually represents. A denial that has gone through mandatory clinician review is a different thing to appeal than one generated without human involvement, and reflects on the submission quality more than on the payers.

‍

Why Texas Remains a State to Watch

‍

Texas’ reforms aren’t necessarily aggressive in the way other states may be – Washington’s timelines are shorter, New Jersey has stricter urgent-drug turnarounds, Illinois has gone so far to prohibit prior authorizations outright for certain services – but Texas makes its mark in terms of influence. Texas’ original gold carding bill set a standard echoed throughout the country, and further, the following bills allowed other states to learn from gaps in the setup before enacting their first. For any organization trying to anticipate where prior authorization policy is headed next, Texas's own revision history is often the clearest signal available.

‍

Bill numbers, effective dates, and provisions reflect available public reporting as of this writing. Confirm current requirements against the Texas Department of Insurance or Texas Legislature before making operational decisions.

‍